Home-Based Technologies Coupled to Teleassistance Service in the Elderly

NCT ID: NCT01697553

Last Updated: 2015-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

1200 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-10-31

Study Completion Date

2016-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The growth of the elderly population is associated with the autonomy failure and the increase of dependence problems. Fall incidents are the third cause of chronic disablement in older persons and are one of the major risk factors for entering in dependence.

The recent progress in home technologies and medical care are opportunities to search how to apply these tools to reduce and prevent falling at home.

The purpose of this study is to evaluate the cost effectiveness of simple home automation pack coupled to teleassistance service for preventing home falls in frail elderly population.

1200 patients will be enrolled and randmosied within two arms:

* home with automation pack coupled to teleassistance service
* home without this technology

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This study is one of the first European randomized studies using the criteria MAST (Model for Assessment of Telemedicine) for medico-economic evaluation of technology solutions for the prevention and care in the elderly. The medico-economic evaluation of the overall contribution of home automation kit associated with telecare will be conducted in accordance with the recommendations of the research program Renewing Health FP7 the European Union. This program has developed an analytical model common to all evaluations of telemedicine applications that have an impact on health.

. The home-based technology in this study will be a simple home automation pack coupled to teleassistance service. The automation pack will include: a remote intercom, an electronic bracelet or pendentive, a pull shower in the bathroom, a light path, a smoke detector and a gas detector in the kitchen. The central hotline will provide telephone support at all times.

Intercom is a remote transmitter which enables the platform to provide remote assistance with the elderly at home.

Each person will have electronic bracelet or pendentive with a medallion which will be provided with the dialer. It is a system that allows remote assistance to the elderly by pressing the central medallion of the device to request assistance or report a dangerous situation (risk of falling, or fall) to the platform of teleassistance.

The bathroom alarm zipper is a device installed in the shower that allows subjects to use it when at risk of falling or fall detection. The shower is a high risk of fall for the elderly due to movements very often results in an imbalance of seniors already weakened by aging.

The light path is a 1.5 m device installed near the bed and turns automatically on when the person sets foot on the ground. It can provide adapted visibility by showing the right path and improving consciousness.

The smoke and gas detector are devices installed on the ceiling of the kitchen. They allow respectively detecting abnormally high rates of smoke or a gas leak in the house or apartment.

The teleassistance platform is a central technical hotline located in Creuse area. It is functional at any time. All electronic devices are connected to the plant. An alert is signaled by an alarm, involving an immediate phone call to the resident of the house to assess the situation. The resulting actions taken are either reassuring the person, giving directions to the person or sending a message to aid in the event ascertained or suspected.

A monthly questionnary should be filled by patients.

Primary outcome:

The main judgment criterion will be the cumulated incidence of home falls requiring emergency admission.

Secondary outcomes:

1. Changes score ISO profile resource according to SMAF scale,
2. Proportion of participants with regular physical activity
3. Effect on admissions in institutions (nursing homes or senior residential care)
4. Time before management of stroke and the length of stay in rehabilitation unit.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Disablement in the Elderly

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Home automation pack coupled to teleassistance service

Group Type EXPERIMENTAL

home automation pack coupled to teleassistance service

Intervention Type OTHER

Home without automation pack coupled to teleassistance service

Group Type ACTIVE_COMPARATOR

Home without automation pack coupled to teleassistance service

Intervention Type OTHER

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

home automation pack coupled to teleassistance service

Intervention Type OTHER

Home without automation pack coupled to teleassistance service

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient aged 65 or over
* Living at least for 1 year in the department of Creuse
* Frail elderly or pre-frail according to the criteria of Fried
* Patient with autonomy enough to get out of bed
* Having a cognitive level acceptable (MMS ≥ 10)
* Place of life arranged and adapted to the installation of the DSTA
* Consentbsigned by the patient and / or its trusted person or his legal representative
* Affiliation or beneficiary of a social security system

Exclusion Criteria

* Patient under guardianship or protection of justice
* patient home already equiped with automation pack different from theone of the experiment
* People who can not read or write
* Diseases involving life-threatening in the short term (\<1 year)
Minimum Eligible Age

65 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Limoges

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thierry DANTOINE, MD

Role: STUDY_CHAIR

CHU Limoges

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CH Aubusson

Aubusson, , France

Site Status NOT_YET_RECRUITING

CH Bourganeuf

Bourganeuf, , France

Site Status NOT_YET_RECRUITING

CH de Gueret

Guéret, , France

Site Status NOT_YET_RECRUITING

CHU Limoges

Limoges, , France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Thierry DANTOINE, MD

Role: CONTACT

0555058621

Achille TCHALLA, MD

Role: CONTACT

055556957

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Thierry DANTOINE, MD

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

I11 001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.